NEW YORK (dpa-AFX Broker) - U.S. bank JPMorgan left Fresenius Medical Care (FMC) at "underweight" with a price target of 17.10 euros after a meeting with CEO Helen Giza. All in all, he interpreted the cautious statements about the new fiscal year 2023 as an indication of a possible decline in earnings at the dialysis specialist in this period, analyst David Adlington wrote in a research note available Wednesday. He said patient numbers remain weak and the cost base is likely to come under pressure./ck/la

Original study publication date: 10/01/2023 / 23:42 / GMT.

First disclosure of original study: 10.01.2023 / 23:45 / GMT

-----------------------

dpa-AFX Broker - Trader News from dpa-AFX

-----------------------